ALZET Osmotic Pumps were developed during the 1970′s by ALZA Corporation.The increasing demand for a commercially available continuous drug delivery device for animal research led to the introduction of ALZET pumps into the marketplace in 1977. In April of 2000, the ALZET product line was acquired by DURECT Corporation. DURECT’s mission is to develop therapies that will improve the quality of life for patients with chronic, debilitating diseases and conditions. To accomplish this goal, DURECT offers a broad range of innovative drug delivery systems that are an essential element to any new controlled-release drug product. DURECT offers sustained release technology platforms that provide delivery of therapeutic candidates from days to years based on the specific therapeutic needs.